Post by Wyss Institute at Harvard University

Using engineered DNA or RNA molecules, nucleic acid therapies treat diseases at their genetic source, offering potential cures for a wide range of disorders, from genetic disorders to cancers and infectious diseases. But, there's a problem. The nucleic acid therapies currently in development struggle to reach the target organs, tissues, and cells most affected by diseases. To find solutions, the Nucleic Acid Delivery Consortium, coordinated at the Wyss Institute, is convening experts in the greater Boston technology system and beyond. The group brings together experts from academia, industry, and venture capital to help unlock novel solutions. Find out more about how you can get involved. https://lnkd.in/edFnJmpv